Medical Properties Trust Inc (MPT) stock analysis
Close on Nov 11, 2026Market cap $1.06BP/E –Yield 17.98%
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed9 of 30 checks passed
Medical Properties Trust passes 9 of the 30 checks behind our score; 15 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 4/6
- Growth
- 1/6
- Past performance
- 1/6
- Financial health
- 0/6
- Dividend
- 3/6
What stands out
Margin of safety over 20%
The price is 77.7% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $1.78 is below our fair value estimate of $7.97.
EV/EBITDA below its 5-year median
Medical Properties Trust's EV/EBITDA of 0.9 is below its 5-year median of 4.2.
P/B below the industry
Medical Properties Trust's price-to-book of 0.24 is below the Miscellaneous Investing median of 1.20.
What to watch
Return on equity under 15%
Return on equity was -0.6% over the last twelve months and averaged -6.5% over five years; we look for 15% on both.
Revenue growing under 10% a year
Revenue grew -14.3% a year over the last three fiscal years, short of the 10% we look for.
Elevated bankruptcy risk
The Altman Z-score is -0.27; above 3 is the safe zone and below 1.8 the distress zone.
Dividend was cut
The dividend per share fell by more than 10% at least once in the last 10 fiscal years.
Valuation4/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA below its 5-year median
Medical Properties Trust's EV/EBITDA of 0.9 is below its 5-year median of 4.2.
P/B below the industry
Medical Properties Trust's price-to-book of 0.24 is below the Miscellaneous Investing median of 1.20.
Trading below fair value
The share price of $1.78 is below our fair value estimate of $7.97.
Margin of safety over 20%
The price is 77.7% below fair value, more than the 20% cushion we look for.
Growth1/6
Revenue growing under 10% a year
Revenue grew -14.3% a year over the last three fiscal years, short of the 10% we look for.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing faster than the industry
Revenue grew 10.6% over the last twelve months; the Miscellaneous Investing median is 4.6%.
Guidance issued
The latest outlook (2027 portfolio cash rents, Oct 29, 2026) was issued for the first time, so it neither adds nor takes away points.
Gross margin trend
This company does not report gross profit.
Past performance1/6
Return on equity under 15%
Return on equity was -0.6% over the last twelve months and averaged -6.5% over five years; we look for 15% on both.
Return on invested capital
Needs operating income and invested capital.
Return on equity below the industry
Medical Properties Trust's return on equity of -0.6% is below the Miscellaneous Investing median of 3.1%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin above its 5-year average
Net margin was -3.0% over the last twelve months, against a 5-year average of -46.7%.
Net margin below the industry
Medical Properties Trust's net margin of -3.0% is below the Miscellaneous Investing median of 10.3%.
Financial health0/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt coverage
Needs operating cash flow.
Interest coverage
Interest expense is not reported separately.
Short-term liquidity
The balance sheet is not split into current and non-current items.
Elevated bankruptcy risk
The Altman Z-score is -0.27; above 3 is the safe zone and below 1.8 the distress zone.
Dividend3/6
Pays a dividend
Medical Properties Trust paid dividends worth 20.2% of the share price over the last twelve months.
Yield above Treasuries
The 20.2% yield is above the 4.4% on a 1-year Treasury.
Yield in the top quarter
The top quarter of US dividend payers yield 3.8% or more; Medical Properties Trust yields 20.2%.
Dividend was cut
The dividend per share fell by more than 10% at least once in the last 10 fiscal years.
Earnings cover
Needs dividends paid and net income.
Cash-flow cover
Needs dividends paid and free cash flow.
Fair value
How we estimate itOur estimate per share
$7.97
The share price is 78% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| EV/EBITDA | 6.8× | 4.2× | 9.5× | $9.59 | 58% |
| P/B | 0.9× | 0.6× | 1.2× | $6.80 | 17% |
| Earnings power | 11.1% cost of equity | – | – | $4.95 | 25% |
| Fair value | $7.97 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 15.1
- Miscellaneous Investing median 26.3
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $48.31M
- Value traded per 1% price move
- $18.77M
Downside
High risk
- Typical loss in a bad month
- 36.7%
- Volatility (annualized)
- 41%
- Sharpe ratio, 1 year
- -1.66
- Beta to the S&P 500 (5Y)
- 1.24
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -2.4% | -14.3% | -4.9% | +8.2% | |
| Gross profit | -4.3% | -13.8% | -6.3% | – | |
| Dividend per share | -15.8% | -34.7% | -21.4% | -9.5% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 8.4% | 6.0% | -5.9% | |
| Return on assets | 3.7% | 2.8% | -1.9% | |
| Interest coverage | 2.1× | – | – | |
| Diluted shares | 261M | 530M | 601M |
Cash use needs five years of cash flow figures
Medical Properties Trust does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -28.5% | 0.07× | 3.10× | -5.9% |
| FY2024 | -242.1% | 0.06× | 2.62× | -38.7% |
| FY2023 | -63.8% | 0.05× | 2.34× | -6.9% |
| FY2022 | 58.5% | 0.08× | 2.36× | 10.6% |
| FY2021 | 42.5% | 0.08× | 2.37× | 8.3% |
| FY2020 | 34.5% | 0.08× | 2.18× | 6.0% |
| FY2019 | 43.9% | 0.07× | 2.01× | 6.5% |
| FY2018 | 129.6% | 0.09× | 2.13× | 24.3% |
| FY2017 | 41.1% | 0.09× | 2.18× | 8.2% |
| FY2016 | 41.6% | 0.09× | 2.25× | 8.4% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero-$277.05M
- Cash generatingOperating cash flow above zero$230.77M
- Return on assets improvedROA up on the prior year-13.2% → -1.9%
- Earnings backed by cashOperating cash flow above net income$230.77M vs -$277.05M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise600M → 601M
- Gross margin improvedGross margin up on the prior year92.55% → 90.71%
- More efficientAsset turnover rose0.05 → 0.07
See a number that looks wrong?